Evaluating the Potential for Cross-Interactions of Antitoxins in Type II TA Systems

Chih-Han Tu1, Michelle Holt1, Shengfeng Ruan1

  • 1Department of Chemistry and Biochemistry, University of Oklahoma, Norman, OK 73019, USA.

Toxins
|July 2, 2020
PubMed

Insights

Type II toxin-antitoxin (TA) systems ensure bacterial survival and can prevent the spread of harmful genes. Their specificity prevents cross-talk, and antitoxins can neutralize invading toxins.

Area of Science:

  • Bacteriology
  • Molecular Biology
  • Genetics

Background:

  • Type II toxin-antitoxin (TA) systems are diverse in bacterial genomes.
  • Interaction specificity is crucial to prevent cross-talk between TA pairs.
  • The benefits of Type II TA systems for host cells are not fully understood.

Purpose of the Study:

  • To review advances in Type II TA system models.
  • To emphasize antitoxin cross-reactivity.
  • To explore interactions with invading genetic elements and toxins with shared folds.

Main Methods:

  • Literature review of Type II TA systems.
  • Analysis of interaction specificity and cross-reactivity.
  • Examination of toxin-antitoxin complexation and toxin folds.

Main Results:

  • Type II TA systems ensure cell protection and survival under stress.
  • They act as a defense against acquisition of similar TA systems from plasmids or mobile elements.
  • Antitoxins can exhibit cross-reactivity with cognate toxins and invading toxins.

Conclusions:

  • Type II TA systems play critical roles in bacterial survival and genome stability.
  • Antitoxin cross-reactivity is a key mechanism for defense against foreign genetic elements.
  • Understanding these systems provides insights into bacterial adaptation and evolution.

Related Concept Videos

Antidotes01:17

Antidotes

Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
938
Cross-reactivity00:42

Cross-reactivity

Overview
32.6K
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.7K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.3K
Antibody Actions01:26

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
2.1K